UBS Group’s SciSparc SPRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $8.15K | Sell |
1,727
-2,791
| -62% | -$15.9K | ﹤0.01% | 9250 |
|
|
2026
Q2 | $24.9K | Buy |
4,518
+1,372
| +44% | +$8.8K | ﹤0.01% | 8017 |
|
|
2026
Q1 | $11.5K | Buy |
3,146
+292
| +10% | +$1.97K | ﹤0.01% | 8298 |
|
|
2025
Q4 | $34.9K | Buy |
2,854
+2,253
| +375% | +$57.3K | ﹤0.01% | 7434 |
|
|
2025
Q3 | $32.7K | Buy |
601
+233
| +63% | +$10.6K | ﹤0.01% | 7837 |
|
|
2025
Q2 | $21.6K | Buy |
+368
| New | +$21.2K | ﹤0.01% | 8374 |
|
|
2025
Q1 | – | Sell |
-283
| Closed | -$19.3K | – | 10697 |
|
|
2024
Q4 | $19.3K | Sell |
283
-82
| -22% | -$3.81K | ﹤0.01% | 7896 |
|
|
2024
Q3 | $16.8K | Buy |
365
+347
| +1,928% | +$29K | ﹤0.01% | 7470 |
|
|
2024
Q2 | $2.68K | Sell |
18
-29
| -62% | -$6.69K | ﹤0.01% | 8314 |
|
|
2024
Q1 | $15.9K | Buy |
47
+8
| +21% | +$5.47K | ﹤0.01% | 7026 |
|
|
2023
Q4 | $36K | Buy |
39
+38
| +3,800% | +$39.9K | ﹤0.01% | 6740 |
|
|
2023
Q3 | $382 | Buy |
+1
| New | +$1.53K | ﹤0.01% | 8533 |
|
|
2023
Q2 | – | Sell |
-3
| Closed | -$6.82K | – | 9593 |
|
|
2023
Q1 | $6.82K | Buy |
3
+2
| +200% | +$7.7K | ﹤0.01% | 7877 |
|
|
2022
Q4 | $2.67K | Sell |
1
-4
| -80% | -$18.7K | ﹤0.01% | 9644 |
|
|
2022
Q3 | $21K | Buy |
5
+4
| +400% | +$24.5K | ﹤0.01% | 7340 |
|
|
2022
Q2 | $11K | Sell |
1
-1
| -50% | -$13.8K | ﹤0.01% | 7843 |
|
|
2022
Q1 | $35K | Buy |
+2
| New | +$48K | ﹤0.01% | 6851 |
|
Other funds holding SPRC
UBS Group's SPRC Position: Q3 2026 in Review
UBS Group reduced its SciSparc (SPRC) stake by 62% in Q3 2026, selling an estimated $15.9K and leaving 1,727 shares worth $8.15K. The position accounts for ﹤0.01% of the portfolio, ranked #9250.
UBS Group first reported a position in SPRC in Q1 2022 and has held it in 17 quarters since. The position peaked at $36K in Q4 2023. 3 funds tracked by Wall St. Rank hold SPRC as of Q3 2026.
- UBS Group held 1,727 shares of SciSparc worth $8.15K as of Q3 2026.
- UBS Group sold 2,791 SciSparc shares in Q3 2026, an estimated $15.9K.
- SciSparc made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #9250 holding.
- UBS Group first reported a position in SciSparc in Q1 2022 and has held it in 17 quarters since.
- UBS Group's SciSparc position peaked at $36K in Q4 2023.
- 3 funds tracked by Wall St. Rank held SciSparc as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.